JAMES SHOU: Open Payments
NPI 1881000271 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,732 in 45 payments from 15 companies in 2025. Trend: 2023 $1,620 · 2024 $1,564 · 2025 $1,732
Food & beverage: $1,542Education: $190
| Company | Payments | Amount |
|---|---|---|
| TG Therapeutics, Inc. | 3 | $365 |
| Teva Pharmaceuticals USA, Inc. | 8 | $287 |
| ABBVIE INC. | 12 | $218 |
| Genentech USA, Inc. | 3 | $196 |
| Amneal Pharmaceuticals LLC | 4 | $190 |
| Neurocrine BioSciences, Inc. | 4 | $120 |
| Axsome Therapeutics, Inc. | 1 | $97 |
| Averitas Pharma Inc. | 2 | $47 |
| PFIZER INC. | 2 | $45 |
| MDD US Operations, LLC | 1 | $42 |
Products named: BRIUMVI, CREXONT, Ocrevus, INGREZZA, QULIPTA, Symbravo, AUSTEDO XR, UBRELVY.
Industry payments across NY — which companies pay providers there.
